Astrana Health Q1 revenue up 56% to $965M; adjusted EBITDA up 82% to $66.3M

Astrana Health, Inc.

2025-Q1 EPS reported $0.29 revenue$965,100,000

Total revenue $965.1M, up 56% YoY; Care Partners revenue $909.7M, up 51%.
Net income attributable to Astrana $14.4M, up 116%; diluted EPS $0.29, up 107%.
Adjusted EBITDA $66.3M, up 82%; adjusted diluted EPS $0.74, up 76%.
Net cash from operations $68.1M (up 309%); free cash flow $64.1M (up 372%).

item 2.02 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

Astrana Health, Inc. reported first quarter ended March 31, 2026 results: revenue $965.1 million, net income $14.4 million, EPS $0.29.

Period: first quarter ended March 31, 2026
Revenue: $965.1 million
Net income: $14.4 million
EPS: $0.29
Result: reported results

Exact text from the filing

Financial Highlights for First Quarter Ended March 31, 2026: All comparisons are to the three months ended March 31, 2025 unless otherwise stated. · Total revenue of $965.1 million, up 56% from $620.4 million · Care Partners revenue of $909.7 million, up 51% from $601.0 million · Net income attributable to Astrana of $14.4 million, up 116% from $6.7 million · Earnings per share (“EPS”) - diluted of $0.29, up 107% from $0.14

View on SEC.gov

Browse all earnings releases →

Astrana Health, Inc. filing history →

Source: SEC EDGAR

accession 0001104659-26-057134

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.